Nagham Jafar1, Hawa Edriss1, Kenneth Nugent2. 1. Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas. 2. Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.. Electronic address: kenneth.nugent@ttuhsc.edu.
Abstract
BACKGROUND: Diabetes mellitus increases the susceptibility to infection by altering both the innate and the adaptive immune systems. Hyperglycemia has been associated with adverse outcomes in hospitalized patients, especially critically ill patients; these poor outcomes are explained in part by hospital-associated infections. MATERIALS AND METHODS: PubMed, EMBASE and Google Scholar were searched to identify studies published between 1970 and 2014 reporting short-term effects of hyperglycemia on the innate immune system. MeSH database search terms included hyperglycemia, immune system, inflammation, inflammation mediators, neutrophils, endothelial dysfunction, complement system proteins and diabetes. Pertinent articles reported studies in healthy volunteers and diabetic patients, using in vitro laboratory experiments, and with animal models. RESULTS: Hyperglycemia activates protein kinase C, and this inhibits neutrophil migration, phagocytosis, superoxide production and microbial killing. High glucose concentrations decrease the formation of neutrophil extracellular traps. Hyperglycemia can also induce Toll-like receptor expression and inhibit neutrophil function and apoptosis. High glucose concentrations decrease vascular dilation and increase permeability during the initial inflammatory responses, possibly through protein kinase C activation. Hyperglycemia can cause direct glycosylation of proteins and alter the tertiary structure of complement; these changes inhibit immunoglobulin-mediated opsonization of bacteria and complement fixation to bacteria and decreases phagocytosis. Hyperglycemia also stimulates the production and release of cytokines. Several trials have demonstrated that better glycemic control reduces nosocomial infections in critically ill patients and surgical site infections. CONCLUSIONS: In summary, acute hyperglycemia can significantly alter innate immune responses to infection, and this potentially explains some of the poor outcomes in hospitalized patients who develop hyperglycemia.
BACKGROUND:Diabetes mellitus increases the susceptibility to infection by altering both the innate and the adaptive immune systems. Hyperglycemia has been associated with adverse outcomes in hospitalized patients, especially critically illpatients; these poor outcomes are explained in part by hospital-associated infections. MATERIALS AND METHODS: PubMed, EMBASE and Google Scholar were searched to identify studies published between 1970 and 2014 reporting short-term effects of hyperglycemia on the innate immune system. MeSH database search terms included hyperglycemia, immune system, inflammation, inflammation mediators, neutrophils, endothelial dysfunction, complement system proteins and diabetes. Pertinent articles reported studies in healthy volunteers and diabeticpatients, using in vitro laboratory experiments, and with animal models. RESULTS:Hyperglycemia activates protein kinase C, and this inhibits neutrophil migration, phagocytosis, superoxide production and microbial killing. High glucose concentrations decrease the formation of neutrophil extracellular traps. Hyperglycemia can also induce Toll-like receptor expression and inhibit neutrophil function and apoptosis. High glucose concentrations decrease vascular dilation and increase permeability during the initial inflammatory responses, possibly through protein kinase C activation. Hyperglycemia can cause direct glycosylation of proteins and alter the tertiary structure of complement; these changes inhibit immunoglobulin-mediated opsonization of bacteria and complement fixation to bacteria and decreases phagocytosis. Hyperglycemia also stimulates the production and release of cytokines. Several trials have demonstrated that better glycemic control reduces nosocomial infections in critically illpatients and surgical site infections. CONCLUSIONS: In summary, acute hyperglycemia can significantly alter innate immune responses to infection, and this potentially explains some of the poor outcomes in hospitalized patients who develop hyperglycemia.
Authors: Dragos Serban; Simona Andreea Balasescu; Catalin Alius; Cristian Balalau; Alexandru Dan Sabau; Cristinel Dumitru Badiu; Bogdan Socea; Andra Maria Trotea; Ana Maria Dascalu; Ion Motofei; Valeriu Ardeleanu; Radu Iulian Spataru; Dan Sabau; Gabriel Catalin Smarandache Journal: Exp Ther Med Date: 2021-05-13 Impact factor: 2.447
Authors: Laura Samuel; Sarah L Szanton; Neal S Fedarko; Eleanor M Simonsick Journal: J Epidemiol Community Health Date: 2020-07-14 Impact factor: 3.710
Authors: Lusha Xiang; Michael S Thompson; John S Clemmer; Peter N Mittwede; Tazim Khan; Robert L Hester Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-02-27 Impact factor: 3.619
Authors: Meena Bedi; David M King; Carlos Mendez; Barbara Slawski; John A Charlson; Donald A Hackbarth; John C Neilson Journal: Clin Orthop Relat Res Date: 2018-03 Impact factor: 4.176